Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

The mTOR signalling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC).